How much time should I budget?

About 3 hours total, a working session and a review call. We do the heavy lifting.

What if I only want the roadmap, not the build?

That's the Campaign Repositioning Sprint. Ship it yourself, or upgrade to Done-For-You later.

Do you interview my customers?

Optional. We can mine your call recordings, reviews, and won/lost notes instead.

B2B teams spending $20K+/mo on ads whose demos aren't converting.

Book a 30-minute call. We'll tell you straight if it's a fit.

Where Speechmatics's ads lose the buyer

Speechmatics is running 14 live ads on LinkedIn and Google. Their average fit to their own ideal buyer is 7.6 out of 10, and 3 ads need fixing. Each ad below is one of Speechmatics’s real live creatives, read straight from the ad libraries.

Speechmatics’s live ads, scored against their buyer

Try Oak free, scored 6/10 against Speechmatics’s ideal buyer. Clinical imagery and model name land the vertical, but no proof point or privacy claim to close the skeptic.
Try Oak free, scored 7/10 against Speechmatics’s ideal buyer. Confidentiality hook nails the HIPAA-sensitive buyer but ranking proof is cut before it registers.
Try Oak free, scored 9/10 against Speechmatics’s ideal buyer. Benchmark chart showing 91.1 vs every named rival gives the technical buyer an instant, undeniable reason to switch.
Try Oak free, scored 8/10 against Speechmatics’s ideal buyer. Multilingual code-switching hook lands the exact pain, but no data proof or privacy angle in view.
Voice AI is getting real. Not just cool demo on a laptop real. This morning at #, scored 5/10 against Speechmatics’s ideal buyer. Event vlog copy signals thought leadership, not a product offer for the builder ICP.
Try Oak free, scored 9/10 against Speechmatics’s ideal buyer. 91.1 vs named rivals across 11 languages is exactly the proof a MedTech developer needs to justify a switch.
Try Oak free, scored 9/10 against Speechmatics’s ideal buyer. Per-language lead over closest competitor is rare, specific proof that speaks directly to multilingual MedTech builders.
Try Oak free, scored 9/10 against Speechmatics’s ideal buyer. Drug-name misrecognition scenario makes the accuracy stakes visceral and immediately credible for clinical scribe builders.
Try Oak free, scored 7/10 against Speechmatics’s ideal buyer. Language breadth visual is compelling.
Try your audio free, scored 8/10 against Speechmatics’s ideal buyer. Benchmark chart across 11 languages beats competitors visually, but self-reported data note slightly undercuts trust.
Try Oak free, scored 7/10 against Speechmatics’s ideal buyer. Code-switching hook lands cleanly for medical AI scribe builders, but proof is absent and offer is vague.
Try Oak free, scored 8/10 against Speechmatics’s ideal buyer. Medication-name error scenario makes the accuracy stakes visceral and immediately credible for healthcare builders.
San Francisco, I want to meet the people actually building voice AI. Not just th, scored 6/10 against Speechmatics’s ideal buyer. Authentic developer-community tone fits the ICP but carries no product claim, proof, or offer to drive a click.
Try Oak free, scored 9/10 against Speechmatics’s ideal buyer. Named-competitor benchmark at 91.1 vs Google, OpenAI, and Deepgram gives evaluators a decisive, scannable reason to switch.

See Speechmatics’s full live-ad board on AdRoast. Every creative scored against their ICP, with the exact fix for each.

Learn the method behind these scores: the AdRoast guides cover how to audit your ads against your ICP and why clicks do not turn into pipeline.